MARKER THERAPEUTICS, INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-43.3% -$2M
$-5M
Free Cash Flow↓-43.3% -$2M
$-5M
Investing Cash Flow
—
Financing Cash Flow↓-100.0% -$15M
$0
Capex
—
Stock Buybacks
—
Stock-Based Comp↑+119.9% +$61K
$111K
D&A
—
SBC Allocated Expense↑+119.3% +$61K
$112K
SBC Unrecognized Cost
$700K